Etiology, Risk Factors, and Management of Asherman Syndrome.
Khan Z.
Obstet Gynecol. 2023 Sep 1;142(3):543-554. doi: 10.1097/AOG.0000000000005309. Epub 2023 Jul 27.
Intrauterine adhesions.
Berman JM.
Semin Reprod Med. 2008 Jul;26(4):349-55. doi: 10.1055/s-0028-1082393.
Supplements to Conventional Treatment After Hysteroscopic Lysis of Intrauterine Adhesions: A Systematic Review.
Konci R, Caminsky N, Tulandi T, Dahan MH.
J Obstet Gynaecol Can. 2020 Aug;42(8):984-1000. doi: 10.1016/j.jogc.2019.09.008. Epub 2019 Dec 24.
Operative laparoscopy.
Rioux JE.
J Reprod Med. 1973 May;10(5):249-55.
Cytokines and Blastocyst Hatching.
Seshagiri PB, Vani V, Madhulika P.
Am J Reprod Immunol. 2016 Mar;75(3):208-17. doi: 10.1111/aji.12464. Epub 2015 Dec 25.
Therapeutic hysteroscopic procedures.
Siegler AM, Valle RF.
Fertil Steril. 1988 Nov;50(5):685-701. doi: 10.1016/s0015-0282(16)60300-x.
A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options.
Salazar CA, Isaacson K, Morris S.
Curr Opin Obstet Gynecol. 2017 Aug;29(4):249-256. doi: 10.1097/GCO.0000000000000378.
Intra-uterine adhesions and fertility outcome: how to optimize success?
Kodaman PH, Arici A.
Curr Opin Obstet Gynecol. 2007 Jun;19(3):207-14. doi: 10.1097/GCO.0b013e32814a6473.
Human amnion as a temporary biologic barrier after hysteroscopic lysis of severe intrauterine adhesions: pilot study.
Amer MI, Abd-El-Maeboud KH, Abdelfatah I, Salama FA, Abdallah AS.
J Minim Invasive Gynecol. 2010 Sep-Oct;17(5):605-11. doi: 10.1016/j.jmig.2010.03.019. Epub 2010 Jun 23.
Human endometrial stromal cells as a source of soluble intercellular adhesion molecule (ICAM)-1 molecules.
Somigliana E, Viganò P, Gaffuri B, Guarneri D, Busacca M, Vignali M.
Hum Reprod. 1996 Jun;11(6):1190-4. doi: 10.1093/oxfordjournals.humrep.a019353.
